Neural stem cell transplantation is an emerging treatment for various neurological ... cell transplantation for chronic thoracic spinal cord injury, Cell Reports Medicine (2024).

An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...

“This type of cellular therapy, though still in its infancy ... axons to connect motor and sensory neurons after spinal injury in humans. Up to this point, most of the work on transplanting neural ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

InVivo Therapeutics is a research and clinical-stage biotechnology company focused on the development of technologies for the treatment of spinal cord injuries ... of a stem cell–Neuro-Spinal ...

Spinal cord injuries ... phase of treatment, physical and occupational therapy aim to improve mobility and daily function. Currently there are no approved pharmaceutical treatments that assist in ...

Multiple babies have been born after receiving the world’s first spina bifida treatment ... The stem cell patch was placed directly over the exposed spinal cord of the fetus.

Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...

Lineage Cell Therapeutics initiates DOSED clinical study of OPC1 for spinal cord injury: Carlsbad, California Thursday, February 13, 2025, 14:00 Hrs [IST] Lineage Cell Therapeutic ...